Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells

Pancreatic ductal adenocarcinoma (PDAC), the fourth leading cause of cancer death, has a 5-year survival rate of approximately 7–9%. The ineffectiveness of anti-PDAC therapies is believed to be due to the existence of a subpopulation of tumor cells known as cancer stem cells (CSCs), which are functi...

Descripción completa

Detalles Bibliográficos
Autores principales: Valle, Sandra, Alcalá, Sonia, Martin-Hijano, Laura, Cabezas-Sáinz, Pablo, Navarro, Diego, Muñoz, Edurne Ramos, Yuste, Lourdes, Tiwary, Kanishka, Walter, Karolin, Ruiz-Cañas, Laura, Alonso-Nocelo, Marta, Rubiolo, Juan A., González-Arnay, Emilio, Heeschen, Christopher, Garcia-Bermejo, Laura, Hermann, Patrick C., Sánchez, Laura, Sancho, Patricia, Fernández-Moreno, Miguel Ángel, Sainz, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567808/
https://www.ncbi.nlm.nih.gov/pubmed/33067432
http://dx.doi.org/10.1038/s41467-020-18954-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567808/
https://www.ncbi.nlm.nih.gov/pubmed/33067432
http://dx.doi.org/10.1038/s41467-020-18954-z

Ejemplares similares